Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells.
Bortoluzzi S, Bisognin A, Biasiolo M, Guglielmelli P, Biamonte F, Norfo R, Manfredini R, Vannucchi AM; AGIMM (Associazione Italiana per la Ricerca sul Cancro–Gruppo Italiano Malattie Mieloproliferative) Investigators. Bortoluzzi S, et al. Among authors: biamonte f. Blood. 2012 Mar 29;119(13):e120-30. doi: 10.1182/blood-2011-07-368001. Epub 2012 Jan 5. Blood. 2012. PMID: 22223824 Free article.
Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNγ-releasing cells: An exploratory study.
Garofalo E, Biamonte F, Palmieri C, Battaglia AM, Sacco A, Biamonte E, Neri G, Antico GC, Mancuso S, Foti G, Torti C, Costanzo FS, Longhini F, Bruni A. Garofalo E, et al. Among authors: biamonte e, biamonte f. PLoS One. 2023 Feb 9;18(2):e0281444. doi: 10.1371/journal.pone.0281444. eCollection 2023. PLoS One. 2023. PMID: 36757971 Free PMC article.
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma.
Battaglia AM, Sacco A, Aversa I, Santamaria G, Palmieri C, Botta C, De Stefano R, Bitetto M, Petriaggi L, Giorgio E, Faniello CM, Costanzo F, Biamonte F. Battaglia AM, et al. Among authors: biamonte f. Front Cell Dev Biol. 2023 Jun 12;11:1208485. doi: 10.3389/fcell.2023.1208485. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37377735 Free PMC article.
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies.
Rotundo S, Borelli M, Scaglione V, Lionello R, Biamonte F, Olivadese V, Quirino A, Morrone HL, Matera G, Costanzo FS, Russo A, Trecarichi EM, Torti C; IDTM UMG COVID-19 Group. Rotundo S, et al. Among authors: biamonte f. Clin Exp Med. 2023 Nov;23(7):3681-3687. doi: 10.1007/s10238-023-01081-6. Epub 2023 Apr 25. Clin Exp Med. 2023. PMID: 37097384 Free PMC article.
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis.
De Vitis C, Battaglia AM, Pallocca M, Santamaria G, Mimmi MC, Sacco A, De Nicola F, Gaspari M, Salvati V, Ascenzi F, Bruschini S, Esposito A, Ricci G, Sperandio E, Massacci A, Prestagiacomo LE, Vecchione A, Ricci A, Sciacchitano S, Salerno G, French D, Aversa I, Cereda C, Fanciulli M, Chiaradonna F, Solito E, Cuda G, Costanzo F, Ciliberto G, Mancini R, Biamonte F. De Vitis C, et al. Among authors: biamonte f. J Exp Clin Cancer Res. 2023 Mar 22;42(1):69. doi: 10.1186/s13046-023-02641-0. J Exp Clin Cancer Res. 2023. PMID: 36945054 Free PMC article.
Editorial: New strategies to tackle chemoresistance in cancer.
De Marco C, Sonego M, Battaglia AM, Viglietto G, Biamonte F. De Marco C, et al. Among authors: biamonte f. Front Oncol. 2022 Oct 25;12:1062921. doi: 10.3389/fonc.2022.1062921. eCollection 2022. Front Oncol. 2022. PMID: 36387111 Free PMC article. No abstract available.
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators. Rosti V, et al. PLoS One. 2010 Dec 9;5(12):e15277. doi: 10.1371/journal.pone.0015277. PLoS One. 2010. PMID: 21151606 Free PMC article.
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Guglielmelli P, Barosi G, Rambaldi A, Marchioli R, Masciulli A, Tozzi L, Biamonte F, Bartalucci N, Gattoni E, Lupo ML, Finazzi G, Pancrazzi A, Antonioli E, Susini MC, Pieri L, Malevolti E, Usala E, Occhini U, Grossi A, Caglio S, Paratore S, Bosi A, Barbui T, Vannucchi AM; AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM) investigators. Guglielmelli P, et al. Among authors: biamonte f. Blood. 2011 Aug 25;118(8):2069-76. doi: 10.1182/blood-2011-01-330563. Epub 2011 Jul 1. Blood. 2011. PMID: 21725052 Free PMC article. Clinical Trial.
105 results